ProfileGDS5822 / ILMN_2960233
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 24% 30% 10% 8% 10% 36% 24% 39% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 113.924
GSM1276600PDAC Late Ablation Control 217.430
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 18.710
GSM1276603PDAC Late Ablation 27.98
GSM1276604PDAC Late Ablation 38.310
GSM1303940PDAC Late Ablation_anti-CTLA4 117.436
GSM1303941PDAC Late Ablation_anti-CTLA4 212.224
GSM1303942PDAC Late Ablation_anti-CTLA4 318.939